You just read:

Eidos Therapeutics Initiates First Clinical Study for AG10 Targeting Transthyretin Amyloidosis, Appoints Camille Landis as Chief Business Officer

News provided by

Eidos Therapeutics

Sep 28, 2017, 08:00 ET